Highlights Pfizer Limited Bombay S.E.

Equities

PFIZER

INE182A01018

Market Closed - Bombay S.E. Other stock markets 03:30:48 08/05/2024 pm IST			5-day change	1st Jan Change
4,276 ^INR	+0.66%		+0.54%	+0.18%

25/04	Pfizer Limited Receives Order from Deputy Commissioner, Dehradun - Sector 8: Uttarakhand	CI
02/04	Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	28/03	CI
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02	CI
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	30/23/30	MT
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/23/28	CI
Pfizer Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	21/23/21	CI
Seagen's breast cancer therapy meets main goal in late-stage study	16/23/16	RE
Pfizer Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Ex-dividend day for extraordinary dividend	11/23/11	FA
Final dividend	11/23/11	FA
Pfizer Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023	27/23/27	CI
Pfizer Limited Initiates Voluntary Recall Of Magnex 1gm, 2gm, Magnex Forte 1.5gm, 3gm, Zosyn 4.5gm and Magnamycin 250mg, 1gm, 2gm Injections	18/23/18	CI
Pfizer Posts Higher Fiscal Q4 Net Profit	16/23/16	MT
Pfizer's India unit posts 3% rise in Q4 profit	15/23/15	RE
Pfizer Limited Recommends A Final Dividend for the Financial Year Ended March 31, 2023, Payable on or Before September 16, 2023	15/23/15	CI
Pfizer Limited Recommends Special Dividend for the Financial Year Ended March 31, 2023, Payable on or Before September 16, 2023	15/23/15	CI
Pfizer Limited Reports Earnings Results for the Full Year Ended March 31, 2023	15/23/15	CI
Pfizer Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	15/23/15	CI
Pfizer Completes Transfer of Thane, India Business to Vidhi Research	27/23/27	MT
Vidhi Research and Development LLP completed the acquisition of Thane Plant from Pfizer Limited.	24/23/24	CI
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09/23/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pfizer Limited Bombay S.E.

Equities

PFIZER

INE182A01018

Highlights

Filters